Skip to content

Mahajan Imaging & Labs joins forces with Fortis La Femme for women's and children's healthcare and diagnostic services in India.

Collaborative effort seeks to establish a health environment for women and children, emphasizing early diagnosis, accurate identification, and tailored therapies

Mahajan Imaging & Labs team up with Fortis La Femme for women's and children's health care and...
Mahajan Imaging & Labs team up with Fortis La Femme for women's and children's health care and diagnostic services in India

Mahajan Imaging & Labs joins forces with Fortis La Femme for women's and children's healthcare and diagnostic services in India.

In a significant move aimed at addressing the growing issue of obesity in India, global healthcare company Novo Nordisk has partnered with leading healthcare provider Apollo Clinics to launch an obesity clinic program.

The partnership, which leverages Apollo Clinics' infrastructure, includes awareness campaigns and digital tools to treat obesity in several Indian cities. This collaboration is particularly noteworthy as it addresses a critical health issue in the country.

Tier 2 and Tier 3 cities are identified as the future of healthcare growth in India. The launch of the obesity clinic program is a step towards improving healthcare services in these regions, with the program expected to be available at multiple locations across the country.

The comprehensive care and treatment provided by the obesity clinic program will be a boon for patients suffering from obesity. This development comes on the heels of positive clinical research findings from Zydus Therapeutics' EPICS-III trial.

Zydus Therapeutics, an Indian pharmaceutical company, conducted a Phase 2(b)/3 trial named EPICS-III. The trial has yielded positive results, with the company reporting topline results from the trial.

The EPICS-III trial was a significant undertaking in the field of obesity research, and its positive outcomes bode well for the future of obesity treatment in India.

Meanwhile, the International Institute of Information Technology, Hyderabad (IIITH) hosted a consultation meeting for ABDM 2.0 (Ayushman Bharat Digital Mission 2.0) in the southern region. The meeting, organized by the National Health Authority (NHA), aimed to discuss the digital mission's future direction and implementation.

Novo Nordisk, a Danish multinational pharmaceutical company, brings its global expertise to this partnership, contributing to the improvement of healthcare services in India. Apollo Clinics, a leading healthcare provider in the country, will utilise its extensive infrastructure to ensure the successful implementation of the obesity clinic program.

The obesity clinic program marks a significant step forward in the fight against obesity in India. With the support of these two prominent organisations, the program is poised to make a meaningful impact on the health of millions of Indians.

Read also: